Max Chaffanet Selected Research

Max Chaffanet Research Topics

Disease

34	Neoplasms (Cancer) 05/2022 - 09/2005
21	Breast Neoplasms (Breast Cancer) 01/2022 - 08/2003
5	Neoplasm Metastasis (Metastasis) 04/2022 - 08/2014
2	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 11/2018
2	Triple Negative Breast Neoplasms 12/2019 - 12/2019
2	Carcinogenesis 11/2014 - 03/2011
2	Myeloproliferative Disorders (Myeloproliferative Disorder) 03/2007 - 01/2003
1	Urologic Neoplasms (Urological Cancer) 05/2022
1	Endometrial Neoplasms (Endometrial Cancer) 04/2022
1	Asthenia 12/2021
1	Pancreatoblastoma 01/2021
1	Brain Neoplasms (Brain Tumor) 05/2019
1	Carcinoma (Carcinomatosis) 12/2017
1	Inflammatory Breast Neoplasms 01/2017
1	Chromosomal Instability (Chromosome Stability) 08/2014
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 03/2014
1	Adenocarcinoma 06/2011
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2010
1	Glioma (Gliomas) 09/2010
1	Pancreatic Neoplasms (Pancreatic Cancer) 08/2003
1	Genetic Translocation (Chromosomal Translocation) 01/2003

Drug/Important Bio-Agent (IBA)

14	DNA (Deoxyribonucleic Acid)IBA 05/2022 - 08/2006
8	Phenobarbital (Luminal)FDA Link 10/2014 - 12/2007
6	Hormones (Hormone)IBA 04/2022 - 03/2011
5	Messenger RNA (mRNA)IBA 03/2015 - 08/2010
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2010
3	Estrogen ReceptorsIBA 10/2014 - 10/2004
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2010 - 01/2003
3	Phosphotransferases (Kinase)IBA 02/2008 - 01/2003
2	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 01/2022 - 12/2021
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 12/2021
2	amitraz (Taktic)IBA 01/2022 - 12/2021
2	Pharmaceutical PreparationsIBA 01/2022 - 12/2021
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2019 - 10/2014
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2018 - 05/2011
2	Myristoylated Alanine-Rich C Kinase SubstrateIBA 12/2017 - 01/2017
2	Biological ProductsIBA 11/2015 - 11/2010
2	Biomarkers (Surrogate Marker)IBA 10/2014 - 06/2011
2	OligonucleotidesIBA 02/2008 - 12/2007
1	RNA (Ribonucleic Acid)IBA 01/2022
1	enfortumab vedotinIBA 01/2022
1	taxaneIBA 01/2022
1	tariquidar (XR9576)IBA 01/2022
1	monomethyl auristatin EIBA 01/2022
1	Circulating Tumor DNAIBA 01/2022
1	NectinsIBA 01/2022
1	Antisense OligonucleotidesIBA 01/2022
1	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 01/2022
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2022
1	HSP27 Heat-Shock ProteinsIBA 01/2022
1	TOR Serine-Threonine KinasesIBA 01/2022
1	CateninsIBA 01/2021
1	folfirinoxIBA 01/2021
1	Cetuximab (Erbitux)FDA Link 12/2019
1	Carboplatin (JM8)FDA LinkGeneric 12/2019
1	P-2 (P 2)IBA 02/2019
1	Trastuzumab (Herceptin)FDA Link 02/2019
1	LipidsIBA 11/2015
1	Nucleic AcidsIBA 11/2015
1	LigandsIBA 03/2015
1	ClaudinsIBA 10/2014
1	SeparaseIBA 08/2014
1	Poly (ADP-Ribose) Polymerase-1IBA 05/2011
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 09/2010
1	Protein Kinases (Protein Kinase)IBA 02/2008
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 02/2008
1	Tyrosine (L-Tyrosine)FDA Link 03/2007
1	Transcription Factors (Transcription Factor)IBA 09/2005
1	Neuregulin-1 (Neuregulin 1)IBA 10/2004
1	ParaffinIBA 10/2004
1	fragile histidine triad proteinIBA 12/2003
1	Dacarbazine (DIC)FDA LinkGeneric 08/2003
1	NeuregulinsIBA 08/2003
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2003

Therapy/Procedure

10	Therapeutics 05/2022 - 03/2011
3	Precision Medicine 05/2022 - 05/2016
2	Drug Therapy (Chemotherapy) 01/2022 - 12/2021
1	Castration 01/2022
1	Neoadjuvant Therapy 02/2019
1	Adjuvant Chemotherapy 08/2014
1	Lasers (Laser) 03/2014